SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001404644-24-000044
Filing Date
2024-04-26
Accepted
2024-04-26 14:33:59
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS neurogeneannualreport2023.pdf ARS 19623696
  Complete submission text file 0001404644-24-000044.txt   27027368
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36327 | Film No.: 24882225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)